Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.03
+0.01000.98%
Volume:30.14K
Turnover:31.31K
Market Cap:15.59M
PE:-1.39
High:1.05
Open:1.04
Low:1.03
Close:1.02
52wk High:1.80
52wk Low:0.7500
Shares:15.14M
Float Shares:12.12M
Volume Ratio:0.59
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:5.78
PE(LYR):-0.83

Loading ...

Biocardia CEO Peter Altman Acquires 5,400 Common Shares Worth $5,208.30

Reuters
·
Jul 09

BioCardia Director Makes Bold Move With Fresh Insider Buy

TIPRANKS
·
Jun 25

Biocardia Director Simon H. Stertzer Acquires 109,200 Common Shares Valued at $103,584

Reuters
·
Jun 25

BioCardia CEO Peter Altman acquires USD 2,043 of common shares

Reuters
·
Jun 22

BioCardia issues letter to shareholders on 2026 priorities

TIPRANKS
·
Jun 18

BioCardia Outlines 2026 CardiAMP Strategy and Milestones

TIPRANKS
·
Jun 18

BioCardia targets Q4 2026 Japan PMDA filing for CardiAMP cell therapy approval

Reuters
·
Jun 18

BioCardia publishes 2026 shareholder letter outlining priorities, strategic opportunities

Reuters
·
Jun 18

BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities

THOMSON REUTERS
·
Jun 18

BioCardia wins Nasdaq extension to Oct. 7 to meet $2.5 million equity rule

Reuters
·
Jun 12

BioCardia CEO Peter Altman acquires 5,000 common shares valued at $4,250

Reuters
·
Jun 10

BioCardia Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 09

BioCardia Raises $4.4 Million to Extend Cash Runway

TIPRANKS
·
Jun 08

BioCardia - Net Proceeds Expected to Extend Cash Runway Into Q1 2027

THOMSON REUTERS
·
Jun 08

Press Release: BioCardia Announces $4.4 Million Financing

Dow Jones
·
Jun 08

Sector Update: Healthcare Stocks Higher Late Afternoon

MT Newswires Live
·
Jun 06

Top Midday Gainers

MT Newswires Live
·
Jun 06

BUZZ-U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia

Reuters
·
Jun 05

BioCardia Gains FDA Path for CardiAMP PMA Approval

TIPRANKS
·
Jun 05

FDA confirms CardiAMP Heart Failure II Trial may support premarket approval

TIPRANKS
·
Jun 05